Amplia Therapeutics (ASX:ATX) has announced a change in its senior management team.
Tim Luscombe will be stepping into the role of Chief Financial Officer, succeeding Hamish George.
Amplia Therapeutics is a biotechnology company focused on developing advanced therapies for serious illnesses.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
